Karakterisasi Rekristalit Antalgin-Fenilbutason dengan Pelarut Aseton sebagai Suatu Sistem Interaksi Fisika

  • Ilma Nugrahani Sekolah Farmasi Institut Teknologi Bandung
  • Slamet Ibrahim Sekolah Farmasi Institut Teknologi Bandung
  • Sundani Nurono Soewandhi Sekolah Farmasi Institut Teknologi Bandung
  • Sukmadjaja Asyarie Sekolah Farmasi Institut Teknologi Bandung

Abstract

Recrystallization with acetone of antalgyne, phenylbutazone, and the mixture of binary system has been characterized. The aim of this research was looking for thermodynamic and x-ray diffraction characteristic of re-crystallite to compare with raw material characteristics. The result used to confirm validity of cool contact methods to identify physical interaction of antalgine-phenylbutazone that has been developed in the preliminary research. Recrystallites characterized by DSC and powder-XRD shows the polymorphism cases, but the co-recrystallite of binary system show the peritecticum physical interaction, similar with the physical interaction of the raw material binary system before recrystallization. Principally, the results of this investigation prove that cool contact methods by acetone could be used for identify physical interaction of antalgine-phenylbutazone.

References

1. Cartensen JT. Solid pharmaceutics: mechanical properties and rate phenomena. New York: Academic Press; 1980. p. 102-108.

2. Davis RE et al. Studies phase relationships in cocrystal systems, american crystallographic association, ACA transaction. 2004; 39: 41-61.

3. Giordano F dan Rossi A. Phase diagrams in the binary system. Boll Chim Farm. 2000; 139(4): 345-9.

4. Nugrahani I, Asyarie S, Soewandhi SN. Metode kontak dingin untuk mendeteksi interaksi fisika pseudoefedrin hidroklorida-parasetamol dan antalgin, fenilbutason (I). Artocarpus Media Pharmaceutica Indonesiana. 2006; (6).

5. Nugrahani I, Murat AS, Asyarie S, Soewandhi SN, Ibrahim S. Konfirmasi metode kontak dingin dengan DSC dan XRD untuk penentuan jenis interaksi fisika pseudoefedrin hidroklorida-parasetamol dan antalgin-fenilbutason(II), Artocarpus Media Pharmaceutica Indonesiana. 2006; (7).

6. Soewandhi SN, Moegihardjo, Pamuji JS, danMauludin R. Profil disolusi campuran peritektik mixed crystal ibuprofen dan asetaminofen, Acta Pharmaceutica Indonesia, 2005; 30: 65-71.
How to Cite
NUGRAHANI, Ilma et al. Karakterisasi Rekristalit Antalgin-Fenilbutason dengan Pelarut Aseton sebagai Suatu Sistem Interaksi Fisika. JURNAL ILMU KEFARMASIAN INDONESIA, [S.l.], v. 5, n. 1, p. 37-44, apr. 2007. ISSN 2614-6495. Available at: <http://jifi.farmasi.univpancasila.ac.id/index.php/jifi/article/view/586>. Date accessed: 22 may 2025.
Citation Formats
Issue
Vol 5 No 1 (2007): JIFI
Section
Articles

Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.

This licence applies to Author(s) and Public Reader means that the users mays :

  • SHARE:
    copy and redistribute the article in any medium or format
  • ADAPT:
    remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication)
  • ALIKE:
    If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original.
  • NO ADDITIONAL RESTRICTIONS:
    You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

It does however mean that when you use it you must:

  • ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

You may not:

  • NONCOMMERCIAL: You may not use the article for commercial purposes.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.